Voluntis raises EUR20.75m co-led by Bpifrance and Innovation Capital
Therapeutic companion software specialist Voluntis has closed a Series D financing co-led by Bpifrance and Innovation Capital, plus Vesalius Biocapital, Qualcomm and existing investors. With a total of EUR20.75 million (USD29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.


